Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
- Author
- SILVERMAN, Lewis R; DEMAKOS, Erin P; ELLERTON, John; LARSON, Richard A; SCHIFFER, Charles A; HOLLAND, James F; PETERSON, Bercedis L; KORNBLITH, Alice B; HOLLAND, Jimmie C; ODCHIMAR-REISSIG, Rosalie; STONE, Richard M; NELSON, Douglas; POWELL, Bayard L; DECASTRO, Carlos M
Cancer and Leukemia Group B. Statistical Center, Duke University Medical Center, Durham, United States
Dana-Farber Cancer Institute, Boston, MA, United States
Mount Sinai School of Medicine and Memorial Sloan-Kettering Cancer Center, New York, United States
State University of New York School of Medicine at Syracuse, Syracuse, NY, United States
University Medical Center S. Nevada Community Clinical Oncology Program, Las Vegas, NV, United States
University of Chicago, Chicago, IL, United States
Wake Forest University Bowman Gray School of Medicine, Winston-Salem, NC, United States
Wayne State University, Detroit, MI, United States - Source
Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2429-2440 ; ref : 88 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Antimétabolite Azacitidine Azanucléoside Chimiothérapie Essai thérapeutique contrôlé Homme Myélodysplasique syndrome Pronostic Randomisation Traitement Triazine dérivé Voie souscutanée Hémopathie maligne
- Keyword (en)
- Antineoplastic agent Antimetabolic Azacitidine Azanucleoside Chemotherapy Controlled therapeutic trial Human Myelodysplastic syndrome Prognosis Randomization Treatment Triazine derivatives Subcutaneous administration Malignant hemopathy
- Keyword (es)
- Anticanceroso Antimetabólito Azacitidina Azanucleósido Quimioterapia Ensayo terapéutico controlado Hombre Mielodisplastico síndrome Pronóstico Aleatorización Tratamiento Triazina derivado Vía subcutánea Hemopatía maligna
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13661784
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2002.04.117 
https://dx.doi.org/10.1200/JCO.2002.04.117
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.04.117\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2429\";s:8:\"\u0000*\u0000epage\";s:4:\"2440\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SILVERMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Lewis R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:15:\"DEMAKOS, Erin P\";i:1;s:14:\"ELLERTON, John\";i:2;s:17:\"LARSON, Richard A\";i:3;s:19:\"SCHIFFER, Charles A\";i:4;s:16:\"HOLLAND, James F\";i:5;s:20:\"PETERSON, Bercedis L\";i:6;s:18:\"KORNBLITH, Alice B\";i:7;s:17:\"HOLLAND, Jimmie C\";i:8;s:25:\"ODCHIMAR-REISSIG, Rosalie\";i:9;s:16:\"STONE, Richard M\";i:10;s:15:\"NELSON, Douglas\";i:11;s:16:\"POWELL, Bayard L\";i:12;s:18:\"DECASTRO, Carlos M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.04.117\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2429\";s:8:\"\u0000*\u0000epage\";s:4:\"2440\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SILVERMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Lewis R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:15:\"DEMAKOS, Erin P\";i:1;s:14:\"ELLERTON, John\";i:2;s:17:\"LARSON, Richard A\";i:3;s:19:\"SCHIFFER, Charles A\";i:4;s:16:\"HOLLAND, James F\";i:5;s:20:\"PETERSON, Bercedis L\";i:6;s:18:\"KORNBLITH, Alice B\";i:7;s:17:\"HOLLAND, Jimmie C\";i:8;s:25:\"ODCHIMAR-REISSIG, Rosalie\";i:9;s:16:\"STONE, Richard M\";i:10;s:15:\"NELSON, Douglas\";i:11;s:16:\"POWELL, Bayard L\";i:12;s:18:\"DECASTRO, Carlos M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.04.117\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.04.117\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2429\";s:8:\"\u0000*\u0000epage\";s:4:\"2440\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SILVERMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Lewis R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:15:\"DEMAKOS, Erin P\";i:1;s:14:\"ELLERTON, John\";i:2;s:17:\"LARSON, Richard A\";i:3;s:19:\"SCHIFFER, Charles A\";i:4;s:16:\"HOLLAND, James F\";i:5;s:20:\"PETERSON, Bercedis L\";i:6;s:18:\"KORNBLITH, Alice B\";i:7;s:17:\"HOLLAND, Jimmie C\";i:8;s:25:\"ODCHIMAR-REISSIG, Rosalie\";i:9;s:16:\"STONE, Richard M\";i:10;s:15:\"NELSON, Douglas\";i:11;s:16:\"POWELL, Bayard L\";i:12;s:18:\"DECASTRO, Carlos M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.04.117\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2429\";s:8:\"\u0000*\u0000epage\";s:4:\"2440\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SILVERMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Lewis R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:15:\"DEMAKOS, Erin P\";i:1;s:14:\"ELLERTON, John\";i:2;s:17:\"LARSON, Richard A\";i:3;s:19:\"SCHIFFER, Charles A\";i:4;s:16:\"HOLLAND, James F\";i:5;s:20:\"PETERSON, Bercedis L\";i:6;s:18:\"KORNBLITH, Alice B\";i:7;s:17:\"HOLLAND, Jimmie C\";i:8;s:25:\"ODCHIMAR-REISSIG, Rosalie\";i:9;s:16:\"STONE, Richard M\";i:10;s:15:\"NELSON, Douglas\";i:11;s:16:\"POWELL, Bayard L\";i:12;s:18:\"DECASTRO, Carlos M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.04.117\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2429\";s:8:\"\u0000*\u0000epage\";s:4:\"2440\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SILVERMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Lewis R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:15:\"DEMAKOS, Erin P\";i:1;s:14:\"ELLERTON, John\";i:2;s:17:\"LARSON, Richard A\";i:3;s:19:\"SCHIFFER, Charles A\";i:4;s:16:\"HOLLAND, James F\";i:5;s:20:\"PETERSON, Bercedis L\";i:6;s:18:\"KORNBLITH, Alice B\";i:7;s:17:\"HOLLAND, Jimmie C\";i:8;s:25:\"ODCHIMAR-REISSIG, Rosalie\";i:9;s:16:\"STONE, Richard M\";i:10;s:15:\"NELSON, Douglas\";i:11;s:16:\"POWELL, Bayard L\";i:12;s:18:\"DECASTRO, Carlos M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:132:\"Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
